Roży A, Duk K, Szumna B, Skrońska P, Gawryluk D, Chorostowska-Wynimko J
Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 26 Płocka St, 01-138, Warsaw, Poland.
Third Department of Lung Disease, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Adv Exp Med Biol. 2016;921:21-6. doi: 10.1007/5584_2016_246.
Current diagnostic methods allow a rapid and reliable detection of active human cytomegalovirus (hCMV) infection by identifying the presence of pp65 CMV antigen or CMV DNA in peripheral blood and affected organs. The goal of this study was to evaluate the effectiveness of CMV detection in blood and organ-specific biological material, such as bronchoalveolar lavage fluid (BALF), by comparing two standard diagnostic methods, immunofluorescence (IF) and the real-time polymerase chain reaction (PCR). We evaluated 25 patients with concomitant respiratory disease who were referred to our hospital for diagnosis due to suspected acute CMV infection. The presence of hCMV was concomitantly evaluated by IF and PCR in 16 peripheral blood samples. In two patients, we observed positive results for both IF and PCR, and in two other patients the results were discordant. Of 11 patients, CMV DNA was detected in six BALF samples, and in one blood plasma sample. Real-time PCR detected CMV DNA in 54.6 % of BALF samples and 12.0 % of blood samples, while indirect IF testing confirmed antigenemia in 12.5 % of blood samples. The results from our study suggest that the IF method is as effective as PCR for detecting an ongoing CMV infection in blood samples. However, real-time PCR was much more effective at detecting CMV DNA in BALF compared to blood samples. Our results suggest that the biological material being tested during CMV diagnosis should be derived directly from the virally infected organ(s).
目前的诊断方法可通过鉴定外周血和受影响器官中pp65巨细胞病毒(hCMV)抗原或CMV DNA的存在,快速可靠地检测活动性人类巨细胞病毒(hCMV)感染。本研究的目的是通过比较两种标准诊断方法,即免疫荧光(IF)和实时聚合酶链反应(PCR),评估血液和器官特异性生物材料(如支气管肺泡灌洗液(BALF))中CMV检测的有效性。我们评估了25例伴有呼吸系统疾病的患者,这些患者因疑似急性CMV感染被转诊至我院进行诊断。对16份外周血样本同时采用IF和PCR评估hCMV的存在情况。在两名患者中,我们观察到IF和PCR结果均为阳性,而在另外两名患者中结果不一致。在11例患者中,在6份BALF样本和1份血浆样本中检测到CMV DNA。实时PCR在54.6%的BALF样本和12.0%的血液样本中检测到CMV DNA,而间接IF检测在12.5%的血液样本中证实存在抗原血症。我们的研究结果表明,IF方法在检测血液样本中正在进行的CMV感染方面与PCR一样有效。然而,与血液样本相比,实时PCR在检测BALF中的CMV DNA方面更有效。我们的结果表明,CMV诊断期间检测的生物材料应直接来自病毒感染的器官。